Share Facebook Twitter Email Telegram WhatsApp Johnson & Johnson said it doesn’t intend to make an offer for Horizon Therapeutics Plc, days after the developer of medicines for rare autoimmune and inflammatory diseases revealed it was in talks with the company.Read More
Corporations try to kill Oklahoma rule that aims to keep medicine by mail from getting too hot or too coldFebruary 8, 2023